Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 3/20 | 0.76 |
| ▸ | CDC25B | P30305 | 2/20 | 0.71 |
| ▸ | ATM | Q13315 | 1/20 | 0.71 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.69 |
| ▸ | LIG1 | P18858 | 1/20 | 0.68 |
| ▸ | CDC25A | P30304 | 1/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29360039 | 1.00 | AKR1C3 (0.76) | AKR1C3CDC25BATMNR4A1LIG1 | |
| SCHEMBL11225742 | 0.91 | LIG1 (0.73) | AKR1C3CDC25BATMNR4A1LIG1 | |
| SCHEMBL27524893 | 0.91 | AKR1C3 (0.91) | AKR1C3CDC25BATMNR4A1CDC25A | |
| SCHEMBL9614636 | 0.91 | LIG1 (0.79) | AKR1C3CDC25BATMNR4A1LIG1 | |
| SCHEMBL30873149 | 0.87 | AKR1C3 (0.83) | AKR1C3CDC25BATMNR4A1CDC25A | |
| SCHEMBL1614614 | 0.87 | AKR1C3 (0.83) | AKR1C3CDC25BATMNR4A1CDC25A | |
| 2-Benzoylbenzoic Acid SCHEMBL76332 | 0.87 | AKR1C3 (1.00) | AKR1C3CDC25BATMNR4A1CDC25A | |
| 2-Benzoylbenzoic Acid SCHEMBL30296847 | 0.87 | AKR1C3 (1.00) | AKR1C3CDC25BATMNR4A1CDC25A | |
| Phthalic Acid SCHEMBL9724323 | 0.87 | ALDH1A1 (0.78) | AKR1C3LIG1POLBTDP1L3MBTL1 | |
| SCHEMBL1219706 | 0.85 | AKR1C3 (0.56) | AKR1C3CDC25BATMNR4A1LIG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7272 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010718-A | Preparation method of 2- (4-hydroxybenzoyl) benzoic acid | 大连中科聚合新材料科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| WO-2026044024-A1 | COMPOSITIONS COMPRISING COMBINATIONS OF PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST AND PHARMACEUTICALLY ACCEPTABLE SALTS AND OTHER DERIVATIVES OF AMYLIN ANALOG, AND USES THEREOF | I2O THERAPEUTICS, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| US-12551465-B2 | Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method using same composition | CELLTRION INC. (KR) | 2026-02-17 | — | — | US | claimed |
| US-20260014144-A1 | USE OF OVATODIOLIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF IN PREVENTION AND TREATMENT OF RENAL FIBROSIS | ZHUJIANG HOSPITAL SOUTHERN MEDICAL UNIV (CN) | 2026-01-15 | — | — | US | claimed |
| US-12440607-B2 | Multifunctional crosslinkers: compounds, compositions, and products thereof | BIOCOAT, INCORPORATED (US) | 2025-10-14 | — | — | US | claimed |
| US-20250197414-A1 | SALT FORM AND CRYSTAL FORM OF VANIN ENZYME INHIBITOR, METHOD FOR PREPARING SAME, AND USE THEREOF | SHANGHAI MEIYUE BIOTECH DEVELOPMENT CO., LTD. (CN) | 2025-06-19 | — | — | US | claimed |
| CN-120081924-A | GLP-1R receptor agonistic polypeptide compounds and uses thereof | 中国药科大学 | 2025-06-03 | — | — | CN | claimed |
| EP-4559465-A1 | USE OF OVATODIOLIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF IN PREVENTION AND TREATMENT OF RENAL FIBROSIS | Zhujiang Hospital of Southern Medical University (CN) | 2025-05-28 | — | — | EP | claimed |
| CN-119954821-A | Cepharanthine derivative and application thereof | 北京化工大学 | 2025-05-09 | — | — | CN | claimed |
| CN-119656175-A | Aminopterin and its structural analogues for treating influenza virus infection | 北京化工大学 | 2025-03-21 | — | — | CN | claimed |
| EP-1928872-A1 | NOVEL SULPHONYLPYRROLES AS INHIBITORS OF HDAC S NOVEL SULPHONYLPYRROLES | Nycomed GmbH (DE) | 2008-06-11 | — | — | EP | claimed |
| WO-2007039404-A1 | NOVEL SULPHONYLPYRROLES AS INHIBITORS OF HDAC S NOVEL SULPHONYLPYRROLES | NYCOMED GMBH (DE) | 2007-04-12 | — | — | WO | claimed |
| US-20060025392-A1 | Combination medicament | ALTANA PHARMA AG (DE) | 2006-02-02 | — | — | US | claimed |
| EP-1572217-A1 | COMBINATION MEDICAMENT | ALTANA Pharma AG (DE) | 2005-09-14 | — | — | EP | claimed |
| US-20040260071-A1 | Benzophene-linked crf and crf-like peptides for covalent labeling of corticotropin-releasing factor crf binding protein | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2004-12-23 | — | — | US | claimed |
| WO-2004052374-A1 | COMBINATION MEDICAMENT | ALTANA PHARMA AG (DE) | 2004-06-24 | — | — | WO | claimed |
| EP-1402271-A2 | BENZOPHENONE-LINKED CRF AND CRF-LIKE PEPTIDES FOR COVALENT LABELING OF CORTICOTROPIN-RELEASING FACTOR (CRF) BINDING PROTEIN | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2004-03-31 | — | — | EP | claimed |
| WO-2002095395-A2 | BENZOPHENONE-LINKED CRF AND CRF-LIKE PEPTIDES FOR COVALENT LABELING OF CORTICOTROPIN-RELEASING FACTOR (CRF) BINDING PROTEIN | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2002-11-28 | — | — | WO | claimed |
| US-6395077-B1 | INKS WITH BENZOYLBENZOIC ACID AND COLORS | XEROX CORPORATION | 2002-05-28 | — | — | US | claimed |
| EP-0468232-B1 | Suspending syrups | SS PHARMACEUTICAL CO (JP) | 1999-02-03 | — | — | EP | claimed |